Cluster page — medicines optimisation
What MO is actually worth to a PCN
Return streams
Why MO is the highest-ROI workstream the PCN owns
The MO investment case stacks on four return streams. Three are robust and quickly measurable; one is supportive. A typical 50,000-patient PCN deploying 2 WTE clinical pharmacists, 1 WTE pharmacy technician and 0.4 WTE Lead Pharmacist time should expect to release 20+ GP hours per week, generate £40k+ in direct prescribing savings, and unlock the SMR component of DES achievement — against an ARRS-reimbursed workforce cost.
Year-one ROI signals
Indicative returns for a 50k PCN
Where the returns come from
Decomposing the ROI
- Repeat prescribing redesign — 4–6 GP hours released per 10k patients per week
- Hypertension and T2DM titration clinics — direct QOF achievement contribution
- Switch programmes — typical £15–25k saving in the first 6 months
- Deprescribing in over-75 cohort — £10–20k annual saving plus falls/cognition outcomes
- HRD monitoring discipline — major medicolegal risk reduction (unquantified but real)
- SMR cohort delivery — DES achievement payment unlocked
Frequently asked questions
MO ROI — FAQs
How is MO ROI measured?+
Four return streams: GP appointment time released (hours per week), direct prescribing cost savings (£ per year), unplanned admission avoidance (estimated against deprescribing trials), and DES achievement payment unlocked. Most PCNs report a 3–5x return on the ARRS investment in MO workforce.
What's the typical year-one ROI for a 50k PCN?+
Indicative: £40k+ prescribing savings from switch and deprescribing programmes, 20+ GP hours per week released through repeat redesign and titration clinics, DES achievement unlocked against SMR cohort target, and significant reductions in HRD-related serious incidents.
How robust is the admission-avoidance figure?+
It is the softest of the four return streams — based on extrapolation from polypharmacy/deprescribing trial outcomes (e.g. anticholinergic deprescribing and falls reduction). Best treated as supportive evidence rather than headline ROI.
How quickly does ROI materialise?+
Prescribing savings begin in month 2–3 of switch programme delivery. GP time release builds from month 3 as pharmacist scope of practice matures. Admission avoidance is a 12–24 month signal. DES achievement is annualised.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.